Holen Sie sich die Stockscreener-App
97.66
0.65%
0.63
Handel nachbörslich:
97.69
0.03
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$97.03
Offen:
$96.69
24-Stunden-Volumen:
8.26M
Relative Volume:
1.10
Marktkapitalisierung:
$125.20B
Einnahmen:
$35.48B
Nettoeinkommen (Verlust:
$4.64B
KGV:
27.26
EPS:
3.582
Netto-Cashflow:
$5.41B
1W Leistung:
+0.83%
1M Leistung:
-3.01%
6M Leistung:
+6.09%
1J Leistung:
+7.63%
1-Tages-Spanne:
$96.30
$98.06
1-Wochen-Bereich:
$95.89
$98.98
52-Wochen-Spanne:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
97.66 | 124.39B | 35.48B | 4.64B | 5.41B | 3.582 |
|
ABT
Abbott Laboratories
|
116.35 | 202.16B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
387.46 | 147.74B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
76.85 | 112.40B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
86.47 | 49.85B | 6.07B | 1.06B | 799.60M | 1.8527 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Fortgesetzt | Barclays | Overweight |
| 2026-02-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
The Sleeper Stock That Could Surge Before Wall Street Notices - The Motley Fool
Medtronic PLC $MDT Shares Acquired by Okabena Investment Services Inc. - MarketBeat
Medtronic (NYSE:MDT) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Daiwa Securities Group Lowers Medtronic (NYSE:MDT) Price Target to $115.00 - MarketBeat
Trivium Point Advisory LLC Increases Stock Holdings in Medtronic PLC $MDT - MarketBeat
Harvest Portfolios Group Inc. Has $61.90 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Primecap Management Co. CA - MarketBeat
Intech Investment Management LLC Sells 53,102 Shares of Medtronic PLC $MDT - MarketBeat
GSA Capital Partners LLP Sells 19,708 Shares of Medtronic PLC $MDT - MarketBeat
Central Securities Corp Buys 75,000 Shares of Medtronic PLC $MDT - MarketBeat
DNB Asset Management AS Has $35.66 Million Position in Medtronic PLC $MDT - MarketBeat
American Century Companies Inc. Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
US Bancorp DE Trims Stake in Medtronic PLC $MDT - MarketBeat
Westfield Capital Management Co. LP Sells 11,893 Shares of Medtronic PLC $MDT - MarketBeat
Daiwa Securities Adjusts Price Target on Medtronic to $115 From $117, Maintains Buy Rating - marketscreener.com
Andra AP fonden Has $30.58 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC (NYSE:MDT) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Medtronic (NYSE:MDT) EVP Sells $5,132,120.04 in Stock - MarketBeat
Medtronic Data Backs Altaviva Tibial Neuromod for Urinary Incontinence - Medical Product Outsourcing
On the Radar: Medtronic - Barron's
Westpac Banking Corp Purchases 34,673 Shares of Medtronic PLC $MDT - MarketBeat
Is Medtronic Stock Underperforming the S&P 500? - Barchart.com
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stake in Medtronic PLC $MDT - MarketBeat
K.J. Harrison & Partners Inc Makes New $1.59 Million Investment in Medtronic PLC $MDT - MarketBeat
TD Asset Management Inc Cuts Position in Medtronic PLC $MDT - MarketBeat
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor - BioSpace
Medtronic (MDT) Launches MiniMed Go Smart MDI System in Europe - GuruFocus
1,326,614 Shares in Medtronic PLC $MDT Acquired by Magellan Asset Management Ltd - MarketBeat
Medtronic’s diabetes business MiniMed looks for $784m in US IPO - Medical Device Network
Medtronic’s MiniMed prices IPO at up to $784M - MedTech Dive
How Investors Are Reacting To Medtronic (MDT) Balancing Growth, Margin Pressure, And A Diabetes Spin-Off - simplywall.st
Medtronic (MDT) Chief Accounting Officer reports bona fide gift of 340 shares - Stock Titan
MiniMed IPO Seeks $784M, Valuing Medtronic Spin-Off at $7.86B - Medical Device and Diagnostic industry
Medtronic's Diabetes Spinoff MiniMed Seeks $742M IPO - Law360
Medtronic diabetes unit MiniMed seeks $784 million in US IPO - Yahoo Finance
Medtronic’s diabetes unit Minimed seeks $784M in IPO - bioworld.com
Medtronic (MDT) Subsidiary MiniMed Group Initiates IPO Roadshow - GuruFocus
Medtronic MiniMed Diabetes unit prices IPO at up to $784M - MassDevice
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off - FinancialContent
Medtronic Unit MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic diabetes unit MiniMed seeks $784 million in IPO By Investing.com - Investing.com Nigeria
MiniMed Launches IPO Roadshow - marketscreener.com
Medtronic Plc Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Medtronic diabetes business MiniMed plans IPO at $25–$28 a share - Stock Titan
Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO - Bloomberg
Miller Investment Management LP Sells 10,280 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic’s diabetes unit MiniMed seeks up to $784M in U.S. IPO - Seeking Alpha
Nkcfo LLC Invests $8.04 Million in Medtronic PLC $MDT - MarketBeat
First Financial Bankshares Inc Buys 13,399 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic's MiniMed targets $7.9 billion valuation in US IPO - marketscreener.com
Medtronic's MiniMed aims to raise $784 million in US IPO - AOL.com
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):